Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

Jeremiah Fowler describes the dataset as 'one of the most dangerous discoveries I have found in a very long time.' He shares ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the recent downgrade of US credit. In a surprising development that led markets to end flat during ...

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...

A 23AndMe spokesperson told Bloomberg that the website delays were due to heavy site traffic. This comes in the wake of the company's weekend bankruptcy filing. In other news: McCormick begins ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Regeneron is set to acquire 23andMe’s consumer genetics and research assets for $256 million. Here’s what the deal means for ...

Salesforce Inc. will offer its Slack application to the federal government at a discounted rate, the latest software company ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.